These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark one)
|
|
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
77-0228183
|
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
|
Identification Number)
|
|
|
|
|
|
|
|
2700 N. First St., San Jose, CA
|
|
95134
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Large accelerated filer [X]
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
|
Smaller reporting company [ ]
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
|
Page
|
|
|
|
Item 1.
|
||
|
||
|
||
|
||
|
||
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
|
|
Item 1.
|
||
Item 1A.
|
||
Item 6.
|
||
|
|
As of
|
||||||
|
December 31,
2016 |
|
October 1,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
405,240
|
|
|
$
|
398,288
|
|
Accounts receivable, net of allowances of $16,866 and $15,081 as of December 31, 2016 and October 1, 2016, respectively
|
993,049
|
|
|
973,680
|
|
||
Inventories
|
963,905
|
|
|
946,239
|
|
||
Prepaid expenses and other current assets
|
55,394
|
|
|
57,445
|
|
||
Total current assets
|
2,417,588
|
|
|
2,375,652
|
|
||
Property, plant and equipment, net
|
620,911
|
|
|
617,524
|
|
||
Deferred tax assets
|
513,020
|
|
|
514,314
|
|
||
Other
|
116,468
|
|
|
117,732
|
|
||
Total assets
|
$
|
3,667,987
|
|
|
$
|
3,625,222
|
|
|
|
|
|
||||
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
1,171,230
|
|
|
$
|
1,121,135
|
|
Accrued liabilities
|
115,371
|
|
|
124,386
|
|
||
Accrued payroll and related benefits
|
105,232
|
|
|
127,326
|
|
||
Short-term debt, including current portion of long-term debt
|
43,416
|
|
|
28,416
|
|
||
Total current liabilities
|
1,435,249
|
|
|
1,401,263
|
|
||
Long-term liabilities:
|
|
|
|
||||
Long-term debt
|
393,298
|
|
|
434,059
|
|
||
Other
|
176,674
|
|
|
180,097
|
|
||
Total long-term liabilities
|
569,972
|
|
|
614,156
|
|
||
Contingencies (Note 5)
|
|
|
|
||||
Stockholders' equity
|
1,662,766
|
|
|
1,609,803
|
|
||
Total liabilities and stockholders' equity
|
$
|
3,667,987
|
|
|
$
|
3,625,222
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands, except per share data)
|
||||||
Net sales
|
$
|
1,719,977
|
|
|
$
|
1,534,714
|
|
Cost of sales
|
1,587,815
|
|
|
1,411,076
|
|
||
Gross profit
|
132,162
|
|
|
123,638
|
|
||
|
|
|
|
||||
Operating expenses:
|
|
|
|
||||
Selling, general and administrative
|
65,140
|
|
|
57,693
|
|
||
Research and development
|
8,171
|
|
|
9,647
|
|
||
Other
|
195
|
|
|
2,245
|
|
||
Total operating expenses
|
73,506
|
|
|
69,585
|
|
||
|
|
|
|
||||
Operating income
|
58,656
|
|
|
54,053
|
|
||
|
|
|
|
||||
Interest income
|
201
|
|
|
148
|
|
||
Interest expense
|
(5,267
|
)
|
|
(5,878
|
)
|
||
Other income (expense), net
|
1,257
|
|
|
(218
|
)
|
||
Interest and other, net
|
(3,809
|
)
|
|
(5,948
|
)
|
||
|
|
|
|
||||
Income before income taxes
|
54,847
|
|
|
48,105
|
|
||
Provision for income taxes
|
9,983
|
|
|
20,967
|
|
||
Net income
|
$
|
44,864
|
|
|
$
|
27,138
|
|
|
|
|
|
||||
Net income per share:
|
|
|
|
||||
Basic
|
$
|
0.61
|
|
|
$
|
0.35
|
|
Diluted
|
$
|
0.58
|
|
|
$
|
0.33
|
|
|
|
|
|
||||
Weighted average shares used in computing per share amounts:
|
|
|
|
||||
Basic
|
73,554
|
|
|
77,921
|
|
||
Diluted
|
77,175
|
|
|
81,205
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
Net income
|
$
|
44,864
|
|
|
$
|
27,138
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
||||
Change in foreign currency translation adjustments
|
(2,156
|
)
|
|
(891
|
)
|
||
Derivative financial instruments:
|
|
|
|
||||
Change in net unrealized amount
|
(2,169
|
)
|
|
364
|
|
||
Amount reclassified into net income
|
1,926
|
|
|
(295
|
)
|
||
Defined benefit plans:
|
|
|
|
||||
Changes in unrecognized net actuarial loss and unrecognized transition cost
|
1,060
|
|
|
375
|
|
||
Amortization of actuarial losses and transition costs
|
599
|
|
|
422
|
|
||
Total other comprehensive loss
|
(740
|
)
|
|
(25
|
)
|
||
Comprehensive income
|
$
|
44,124
|
|
|
$
|
27,113
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(Unaudited)
|
||||||
|
(In thousands)
|
||||||
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
|
|
|
|
||||
Net income
|
$
|
44,864
|
|
|
$
|
27,138
|
|
Adjustments to reconcile net income to cash provided by (used in) operating activities:
|
|
|
|
||||
Depreciation and amortization
|
28,972
|
|
|
25,751
|
|
||
Stock-based compensation expense
|
11,977
|
|
|
4,052
|
|
||
Deferred income taxes
|
1,477
|
|
|
12,326
|
|
||
Other, net
|
644
|
|
|
1,270
|
|
||
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
||||
Accounts receivable
|
(22,849
|
)
|
|
5,848
|
|
||
Inventories
|
(19,306
|
)
|
|
22,508
|
|
||
Prepaid expenses and other assets
|
1,614
|
|
|
429
|
|
||
Accounts payable
|
39,391
|
|
|
(12,557
|
)
|
||
Accrued liabilities
|
(32,857
|
)
|
|
(24,105
|
)
|
||
Cash provided by operating activities
|
53,927
|
|
|
62,660
|
|
||
|
|
|
|
||||
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
|
|
|
|
||||
Purchases of property, plant and equipment
|
(21,667
|
)
|
|
(28,910
|
)
|
||
Proceeds from sales of property, plant and equipment
|
3,582
|
|
|
202
|
|
||
Cash used in investing activities
|
(18,085
|
)
|
|
(28,708
|
)
|
||
|
|
|
|
||||
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
|
|
|
|
||||
Proceeds from revolving credit facility borrowings
|
208,400
|
|
|
770,500
|
|
||
Repayments of revolving credit facility borrowings
|
(233,400
|
)
|
|
(794,500
|
)
|
||
Net proceeds from stock issuances
|
10,643
|
|
|
4,310
|
|
||
Repurchases of common stock
|
(13,623
|
)
|
|
(28,694
|
)
|
||
Holdback payment for a prior business combination
|
(2,262
|
)
|
|
—
|
|
||
Cash used in financing activities
|
(30,242
|
)
|
|
(48,384
|
)
|
||
|
|
|
|
||||
Effect of exchange rate changes
|
1,352
|
|
|
626
|
|
||
Increase (decrease) in cash and cash equivalents
|
6,952
|
|
|
(13,806
|
)
|
||
Cash and cash equivalents at beginning of period
|
398,288
|
|
|
412,253
|
|
||
Cash and cash equivalents at end of period
|
$
|
405,240
|
|
|
$
|
398,447
|
|
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Interest, net of capitalized interest
|
$
|
8,543
|
|
|
$
|
8,957
|
|
Income taxes, net of refunds
|
$
|
5,593
|
|
|
$
|
9,339
|
|
|
|
|
|
|
As of
|
||||||
|
December 31,
2016 |
|
October 1,
2016 |
||||
|
(In thousands)
|
||||||
Raw materials
|
$
|
695,421
|
|
|
$
|
671,240
|
|
Work-in-process
|
128,848
|
|
|
144,355
|
|
||
Finished goods
|
139,636
|
|
|
130,644
|
|
||
Total
|
$
|
963,905
|
|
|
$
|
946,239
|
|
|
As of
|
||||||
|
December 31, 2016
|
|
October 1, 2016
|
||||
Derivatives Designated as Accounting Hedges:
|
|
|
|
||||
Notional amount (in thousands)
|
$
|
81,121
|
|
|
$
|
110,242
|
|
Number of contracts
|
47
|
|
|
43
|
|
||
Derivatives Not Designated as Accounting Hedges:
|
|
|
|
||||
Notional amount (in thousands)
|
$
|
339,304
|
|
|
$
|
313,558
|
|
Number of contracts
|
51
|
|
|
46
|
|
|
As of
|
||||||
|
December 31,
2016 |
|
October 1,
2016 |
||||
|
(In thousands)
|
||||||
Secured debt due 2017
|
$
|
40,000
|
|
|
$
|
40,000
|
|
Senior secured notes due 2019
|
375,000
|
|
|
375,000
|
|
||
Non-interest bearing promissory notes
|
21,714
|
|
|
22,475
|
|
||
Total long-term debt
|
436,714
|
|
|
437,475
|
|
||
Less: Current portion (includes Secured debt due 2017)
|
43,416
|
|
|
3,416
|
|
||
Long-term debt
|
$
|
393,298
|
|
|
$
|
434,059
|
|
|
As of
|
||||||
|
December 31,
2016 |
|
October 1,
2016 |
||||
|
(In thousands)
|
||||||
Foreign currency translation adjustments
|
$
|
88,208
|
|
|
$
|
90,364
|
|
Unrealized holding losses on derivative financial instruments
|
(682
|
)
|
|
(439
|
)
|
||
Unrecognized net actuarial loss and transition cost for benefit plans
|
(22,885
|
)
|
|
(24,544
|
)
|
||
Total
|
$
|
64,641
|
|
|
$
|
65,381
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Gross sales:
|
|
|
|
||||
IMS
|
$
|
1,414,270
|
|
|
$
|
1,239,268
|
|
CPS
|
351,074
|
|
|
345,648
|
|
||
Intersegment revenue
|
(45,367
|
)
|
|
(50,202
|
)
|
||
Net sales
|
$
|
1,719,977
|
|
|
$
|
1,534,714
|
|
|
|
|
|
||||
Gross profit:
|
|
|
|
||||
IMS
|
$
|
102,637
|
|
|
$
|
95,609
|
|
CPS
|
33,289
|
|
|
30,102
|
|
||
Total
|
135,926
|
|
|
125,711
|
|
||
Unallocated items (1)
|
(3,764
|
)
|
|
(2,073
|
)
|
||
Total
|
$
|
132,162
|
|
|
$
|
123,638
|
|
(1)
|
For purposes of evaluating segment performance, management excludes certain items from its measures of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, charges or credits resulting from distressed customers and acquisition-related items.
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Net sales
|
|
|
|
||||
United States
|
$
|
299,876
|
|
|
$
|
254,379
|
|
Mexico
|
474,160
|
|
|
484,970
|
|
||
China
|
321,739
|
|
|
367,259
|
|
||
Malaysia
|
211,191
|
|
|
46,608
|
|
||
Other international
|
413,011
|
|
|
381,498
|
|
||
Total
|
$
|
1,719,977
|
|
|
$
|
1,534,714
|
|
Percentage of net sales represented by ten largest customers
|
51.8
|
%
|
|
48.2
|
%
|
Number of customers representing 10% or more of net sales
|
2
|
|
|
—
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands, except per share data)
|
||||||
Numerator:
|
|
|
|
||||
Net income
|
$
|
44,864
|
|
|
$
|
27,138
|
|
|
|
|
|
||||
Denominator:
|
|
|
|
||||
Weighted average common shares outstanding
|
73,554
|
|
|
77,921
|
|
||
Effect of dilutive stock options and restricted stock units
|
3,621
|
|
|
3,284
|
|
||
Denominator for diluted earnings per share
|
77,175
|
|
|
81,205
|
|
||
|
|
|
|
||||
Net income per share:
|
|
|
|
||||
Basic
|
$
|
0.61
|
|
|
$
|
0.35
|
|
Diluted
|
$
|
0.58
|
|
|
$
|
0.33
|
|
|
Three Months Ended
|
||||
|
December 31,
2016 |
|
January 2,
2016 |
||
|
(In thousands)
|
||||
Potentially dilutive securities:
|
|
||||
Employee stock options
|
29
|
|
|
779
|
|
Restricted stock units
|
72
|
|
|
2
|
|
Total
|
101
|
|
|
781
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Stock options
|
$
|
550
|
|
|
$
|
1,240
|
|
Restricted stock units, including performance based awards
|
11,427
|
|
|
2,812
|
|
||
Total
|
$
|
11,977
|
|
|
$
|
4,052
|
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Cost of sales
|
$
|
2,864
|
|
|
$
|
1,405
|
|
Selling, general and administrative
|
8,840
|
|
|
2,566
|
|
||
Research and development
|
273
|
|
|
81
|
|
||
Total
|
$
|
11,977
|
|
|
$
|
4,052
|
|
|
Number of
Shares
|
|
Weighted-
Average
Exercise Price
($)
|
|
Weighted-
Average
Remaining
Contractual
Term
(Years)
|
|
Aggregate
Intrinsic
Value of
In-The-Money
Options
($)
|
|||
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|||
Outstanding as of October 1, 2016
|
5,514
|
|
|
12.75
|
|
|
4.10
|
|
81,659
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|
Exercised/Cancelled/Forfeited/Expired
|
(709
|
)
|
|
15.04
|
|
|
|
|
|
|
Outstanding as of December 31, 2016
|
4,805
|
|
|
12.41
|
|
|
4.03
|
|
113,109
|
|
Vested and expected to vest as of December 31, 2016
|
4,786
|
|
|
12.37
|
|
|
4.02
|
|
112,836
|
|
Exercisable as of December 31, 2016
|
4,542
|
|
|
11.86
|
|
|
3.82
|
|
109,411
|
|
|
Number of
Shares
|
|
Weighted-
Average Grant Date
Fair Value
($)
|
|
Weighted-
Average
Remaining
Contractual
Term
(Years)
|
|
Aggregate
Intrinsic
Value
($)
|
|||
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|||
Outstanding as of October 1, 2016
|
3,998
|
|
|
19.57
|
|
|
1.35
|
|
110,183
|
|
Granted
|
941
|
|
|
32.56
|
|
|
|
|
|
|
Vested/Forfeited/Cancelled
|
(1,406
|
)
|
|
13.42
|
|
|
|
|
|
|
Outstanding as of December 31, 2016
|
3,533
|
|
|
23.35
|
|
|
1.81
|
|
127,011
|
|
Expected to vest as of December 31, 2016
|
2,756
|
|
|
24.51
|
|
|
1.83
|
|
99,093
|
|
1.
|
Integrated Manufacturing Solutions (IMS). IMS is a reportable segment consisting of printed circuit board assembly and test, final system assembly and test, and direct-order-fulfillment.
|
2.
|
Components, Products and Services (CPS). Components include interconnect systems (printed circuit board fabrication, backplane and cable assemblies) and mechanical systems (enclosures, precision machining and plastic injection molding). Products include memory, RF, optical and microelectronics solutions from our Viking Technology division, defense and aerospace products from SCI Technology, storage solutions from our Newisys division and cloud-based manufacturing execution software from our 42Q Division. Services include design, engineering, logistics and repair services.
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Net sales
|
$
|
1,719,977
|
|
|
$
|
1,534,714
|
|
Gross profit
|
$
|
132,162
|
|
|
$
|
123,638
|
|
Operating income
|
$
|
58,656
|
|
|
$
|
54,053
|
|
Net income
|
$
|
44,864
|
|
|
$
|
27,138
|
|
|
Three Months Ended
|
||||||||||||
|
December 31, 2016
|
|
January 2, 2016
|
|
Increase/(Decrease)
|
||||||||
Communications Networks
|
$
|
642,589
|
|
|
$
|
604,765
|
|
|
$
|
37,824
|
|
6.3
|
%
|
Industrial, Medical and Defense
|
777,497
|
|
|
609,804
|
|
|
167,693
|
|
27.5
|
%
|
|||
Embedded Computing and Storage
|
299,891
|
|
|
320,145
|
|
|
(20,254
|
)
|
(6.3
|
)%
|
|||
Total
|
$
|
1,719,977
|
|
|
$
|
1,534,714
|
|
|
$
|
185,263
|
|
12.1
|
%
|
•
|
Changes in customer demand and sales volumes for our vertically integrated system components and
|
•
|
Changes in the overall volume of our business, which affect the level of capacity utilization;
|
•
|
Changes in the mix of high and low margin products demanded by our customers;
|
•
|
Parts shortages and operational disruption caused by natural disasters;
|
•
|
Greater competition in the EMS industry and pricing pressures from OEMs due to greater focus on cost reduction;
|
•
|
Provisions for excess and obsolete inventory, including provisions associated with distressed customers;
|
•
|
Level of operational efficiency;
|
•
|
Wage inflation and rising materials costs; and
|
•
|
Our ability to transition the location of manufacturing and assembly operations when requested by a customer in an efficient manner.
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Foreign exchange gain (loss)
|
$
|
1,226
|
|
|
$
|
(829
|
)
|
Other income, net
|
31
|
|
|
611
|
|
||
Total
|
$
|
1,257
|
|
|
$
|
(218
|
)
|
|
Three Months Ended
|
||||||
|
December 31,
2016 |
|
January 2,
2016 |
||||
|
(In thousands)
|
||||||
Net cash provided by (used in):
|
|
|
|
||||
Operating activities
|
$
|
53,927
|
|
|
$
|
62,660
|
|
Investing activities
|
(18,085
|
)
|
|
(28,708
|
)
|
||
Financing activities
|
(30,242
|
)
|
|
(48,384
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
1,352
|
|
|
626
|
|
||
Increase (decrease) in cash and cash equivalents
|
$
|
6,952
|
|
|
$
|
(13,806
|
)
|
|
Three Months Ended
|
||
|
December 31,
2016 |
|
October 1,
2016 |
Days sales outstanding (1)
|
52
|
|
53
|
Inventory turns (2)
|
6.7
|
|
6.6
|
Days inventory on hand (3)
|
55
|
|
55
|
Accounts payable days (4)
|
66
|
|
66
|
Cash cycle days (5)
|
41
|
|
42
|
(1)
|
Days sales outstanding (a measure of how quickly we collect our accounts receivable), or "DSO", is calculated as the ratio of average accounts receivable, net, to average daily net sales for the quarter.
|
(2)
|
Inventory turns (annualized) are calculated as the ratio of four times our cost of sales for the quarter to average inventory.
|
(3)
|
Days inventory on hand is calculated as the ratio of average inventory for the quarter to average daily cost of sales for the quarter.
|
(4)
|
Accounts payable days (a measure of how quickly we pay our suppliers), or "DPO", is calculated as the ratio of 365 days divided by accounts payable turns, in which accounts payable turns is calculated as the ratio of four times our cost of sales for the quarter to average accounts payable.
|
(5)
|
Cash cycle days is calculated as days inventory on hand plus days sales outstanding minus accounts payable days.
|
•
|
intense competition among our customers and their competitors, leading to reductions in prices for their products and pricing pressures on us;
|
•
|
short product life cycles of our customers' products leading to continuing new requirements and specifications and product obsolescence, either of which could cause us to lose business;
|
•
|
failure of our customers' products to gain widespread commercial acceptance which could decrease the volume of orders customers place with us; and
|
•
|
recessionary periods in our customers' markets, including the currently depressed conditions in the oil and gas industry, which decrease orders from affected customers.
|
•
|
the imposition of government controls;
|
•
|
compliance with U.S and foreign laws concerning trade (including the International Traffic in Arms Regulations (“ITAR”), the Export Administration Regulations (“EAR”) and the Foreign Corrupt Practices Act (“FCPA”);
|
•
|
difficulties in obtaining or complying with export license requirements;
|
•
|
changes in tariffs;
|
•
|
rising labor costs;
|
•
|
compliance with foreign labor laws, which generally provide for increased notice, severance and consultation requirements compared to U.S. laws;
|
•
|
labor unrest, including strikes;
|
•
|
difficulties in staffing due to immigration or travel restrictions imposed by national governments;
|
•
|
security concerns;
|
•
|
political instability and/or regional military tension or hostilities;
|
•
|
inflexible employee contracts or labor laws in the event of business downturns;
|
•
|
coordinating communications among and managing international operations;
|
•
|
fluctuations in currency exchange rates, which may either increase or decrease our operating costs and for which we have significant exposure;
|
•
|
currency controls;
|
•
|
changes in tax and trade laws that increase our local costs;
|
•
|
exposure to heightened corruption risks;
|
•
|
aggressive, selective or lax enforcement of laws and regulations by national governmental authorities;
|
•
|
adverse rulings in regards to tax audits; and
|
•
|
misappropriation of intellectual property.
|
•
|
conditions in the economy as a whole and in the industries we serve;
|
•
|
fluctuations in components prices and component shortages caused by high demand, natural disaster or otherwise;
|
•
|
timing of new product development by our customers, which creates demand for our services, but which can also require us to incur start-up costs relating to new tooling and processes;
|
•
|
levels of demand in the end markets served by our customers;
|
•
|
our ability to replace declining sales from end-of-life programs with new business wins;
|
•
|
timing of orders from customers and the accuracy of their forecasts;
|
•
|
inventory levels of customers, which if high relative to their normal sales volume, could cause them to reduce their orders to us;
|
•
|
timing of expenditures in anticipation of increased sales, customer product delivery requirements and shortages of components or labor;
|
•
|
increased labor costs in the regions in which we operate;
|
•
|
mix of products ordered by and shipped to major customers, as high volume and low complexity manufacturing services typically have lower gross margins than more complex and lower volume services;
|
•
|
degree to which we are able to utilize our available manufacturing capacity;
|
•
|
customer insolvencies resulting in bad debt or inventory exposures that are in excess of our reserves;
|
•
|
our ability to efficiently move manufacturing activities to lower cost regions;
|
•
|
the effects of seasonality in our business;
|
•
|
changes in our tax provision due to changes in our estimates of pre-tax income in the jurisdictions in which we operate, uncertain tax positions, including our ability to utilize our deferred tax assets; and
|
•
|
political and economic developments in countries in which we have operations which could restrict our operations or increase our costs.
|
Exhibit Number
|
|
Description
|
|
|
|
31.1
|
|
Certification of the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
|
|
31.2
|
|
Certification of the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
|
|
32.1 (1)
|
|
Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
|
|
|
32.2 (1)
|
|
Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1)
|
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
|
|
|
SANMINA CORPORATION
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ JURE SOLA
|
|
|
|
Jure Sola
|
|
|
|
Chief Executive Officer (Principal Executive Officer)
|
|
|
|
|
Date:
|
February 3, 2017
|
|
|
|
|
|
|
|
|
By:
|
/s/ ROBERT K. EULAU
|
|
|
|
Robert K. Eulau
|
|
|
|
Executive Vice President and
|
|
|
|
Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
Date:
|
February 3, 2017
|
|
Exhibit Number
|
|
Description
|
|
|
|
31.1
|
|
Certification of the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
|
|
31.2
|
|
Certification of the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
|
|
|
|
32.1(1)
|
|
Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
|
|
|
32.2(1)
|
|
Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1)
|
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|